Concepción Cepeda

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression

José Ramón Arribas, Federico Pulido, Rafaël Delgado et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 149 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors

Marisa Montes, Federico Pulido, Carlos Barrós et al. · Journal of Antimicrobial Chemotherapy · 2005 · 82 citations

Medicine, Pharmacokinetics, Pharmacology +16

Clinical, Virologic, and Immunologic Response to Efavirenz-or Protease Inhibitor???Based Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive Patients With Advanced HIV Infection (EfaVIP 2 Study)

Federico Pulido, José Ramón Arribas, Jose M Mir et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 63 citations

Life Sciences, Immunology, Pharmacotherapy +17

Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic Impairment

Joanna Peng, Federico Pulido, Sonja J. Causemaker et al. · The Journal of Clinical Pharmacology · 2006 · 45 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

Asunción Díaz, Mercedes Díez, María José Bleda et al. · BMC Infectious Diseases · 2010 · 19 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +17